INTENDED FOR UK AND IRELAND HEALTHCARE PROFESSIONALS HomePrescribing information

The exact mode of action of Bronchitol is unknown, but it is believed to target the underlying pathophysiological airways’ mechanisms in cystic fibrosis by:

  • Altering the viscoelastic properties of mucus
  • Increasing the hydration of the periciliary fluid layer
  • Contributing to increased mucus clearance through mucociliary activity.1